Results 231 to 240 of about 2,150,399 (264)

A 73‐Year‐Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT A 73‐year‐old man presented with progressive weakness and atrophy predominantly affecting the distal finger flexors and quadriceps muscles. Electrophysiological studies demonstrated mixed myogenic and neurogenic features. Muscle MRI showed inflammatory changes, and muscle biopsy revealed granulomatous myositis with histologic features ...
Mehmet Can Sari, Arens Taga, Sonya Ulrike Steele, Ahmet Hoke   +3 more
wiley   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Flipped online teaching of histology and embryology with design thinking: design, practice and reflection. [PDF]

BMC Med Educ
Guo Y, Wang X, Gao Y, Yin H, Ma Q, Chen T.   +5 more
europepmc   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Construire un Design Thinking Agile en utilisant le Customer Journey Map

Technologie et Innovation
Alaa HASSAN, Laure MOREL
doaj   +1 more source

Developing pharmacy leaders: A design thinking approach to navigate the leadership crisis in pharmacy. [PDF]

Can Pharm J (Ott)
Byers K, Gee A, Anwar M.
europepmc   +1 more source

Leveraging Co-Design, Design Thinking, and Service Blueprinting to Create Digital Health Behavior Change Innovations: Insights From a Co-Design Workshop With Type 2 Diabetes Remission Health Coaches. [PDF]

J Diabetes Sci Technol
Vela R, Voorheis P, Petch J, Gerstein H, Sherifali D.   +4 more
europepmc   +1 more source

Revisiting the hospital-issued gown in hospitalizations from a locus of control and patient-centered care perspectives: a call for design thinking. [PDF]

Front Public Health
Gabay G, Ornoy H.
europepmc   +1 more source

Leveraging systems science and design thinking to advance implementation science: moving toward a solution-oriented paradigm. [PDF]

Front Public Health
Huang TT, Callahan EA, Haines ER, Hooley C, Sorensen DM, Lounsbury DW, Sabounchi NS, Hovmand PS.   +7 more
europepmc   +1 more source